- This event has passed.
Chemistry at the Frontline of Coronavirus – ACS Publications Webinar
May 3, 2022 @ 2:00 pm - May 4, 2022 @ 12:00 am PDT
Free
A two-session virtual event featuring eight speakers and their highly cited articles on the characterization, detection, and prevention of COVID-19.
Wednesday, May 4, 2022
- Session 1: 8:00AM EDT | 7:00AM CDT | 6:00AM MDT | 5:00AM PDT
- Session 2: 4:00PM EDT | 3:00PM CDT | 2:00PM MDT | 1:00PM PDT
Register: https://connect.acspubs.org/frontlinecoronavirus
The COVID-19 pandemic has presented myriad challenges that have been and will continue to be overcome through exceedingly rapid scientific advancement. In the midst of these developments, scientists also had to adapt and change the way they conduct research and collaborate, making the pace of their discoveries all the more impressive. As a credit to their tireless efforts and resilience, researchers developed approaches to improve or establish our ability to prevent, detect, and treat COVID-19, as well as to build the toolkit of available technologies in the event of future pandemics.
With this virtual event, we are pleased to feature the authors of some of the most highly read and cited articles in ACS biological and analytical chemistry journals that shed light on aspects of SARS-CoV-2 and the COVID-19 pandemic. This is in follow up to our popular Chemistry in Coronavirus webinar from summer 2020 – it is exciting to witness the amount of progress made toward addressing the COVID-19 pandemic between that time and now.
We hope you will join us to hear from 8 exciting speakers as they highlight their work relating to the characterization and detection of SARS-CoV-2, and prevention of COVID-19.
Agenda
Session 1 – 8:00AM – 10:05AM EDT (5:00-7:05AM PT)
8:00AM – 8:05AM – Welcome and introduction by Nicole Camasso, Lorraine Clark, and Christina MacLaughlin
8:05AM – 8:35AM – Metabolic Phenotyping to Assess Long-COVID in COVID-19 Patients by Elaine Holmes (Murdoch University)
8:35AM – 9:05AM – Innovative FO-SPR Label-Free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood by Dragana Spasic (KU Leuven)
9:05AM – 9:35AM – Rapid Discovery of Potent Inhibitors of the Main Protease of SARS-CoV2 by William Jorgensen (Yale University)
9:35AM – 10:05AM – Evaluation of Novel Computationally Designed SARS-CoV-2 Protease Inhibitors as Promising Preclinical Candidates by Karen Anderson (Yale University)
Session 2 – 4:00PM – 6:05PM EDT (1:00-3:00PM PT)
4:00PM – 4:05PM – Welcome and introduction by Nicole Camasso, Lorraine Clark, and Christina MacLaughlin
4:05PM – 4:35PM – Discovery of Cannabinoid Acid Inhibitors of Cellular Entry by SARS-CoV-2 by Richard van Breemen (Oregon State University)
4:35PM – 5:05PM – Discovering the Mechanisms of SARS-CoV-2 Evolution and Transmission by Guowei Wei (Michigan State University)
5:05PM – 5:35PM – The Conserved Macrodomain is a Novel Therapeutic Target of Coronaviruses by Anthony Leung (Johns Hopkins)
5:35PM – 6:05PM – Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival by Binquan Luan (IBM)